Showing 2581-2590 of 5771 results for "".
- Retina Consultants of America Announces New Alliancehttps://modernod.com/news/retina-consultants-of-america-announces-new-alliance/2478304/VitreoRetinal Surgery PA, based in Minnesota, has joined Retina Consultants of America (RCA). This is the sixth retina specialty practice to join RCA as it continues to expand the company’s footprint across the United States, including California Retina Consultants, Retina Consultants of Housto
- Regenxbio Announces Additional Positive Interim Phase 1/2a Trial Update for RGX-314 for the Treatment of Wet AMDhttps://modernod.com/news/regenxbio-announces-additional-positive-interim-phase-1-2a-trial-update-for-rgx-314-for-the-treatment-of-wet-amd-2/2478113/Regenxbio reported positive 1 year data from patients in Cohorts 4 and 5 of the phase 1/2a trial of RGX-314 for the treatment of wet age-related macular degeneration (AMD). The company plans to initiate a pivotal program for subretinal delivery of RGX-314 in patients with wet AMD by the end of 20
- Trump Administration Announces $5B COVID-19 Relief Funds, Future Testing Requirements for Nursing Homeshttps://modernod.com/news/trump-administration-announces-5b-covid-19-relief-funds-future-testing-requirements-for-nursing-homes/2478064/The Trump administration is allocating an additional $5 billion in COVID-19 relief funds to Medicare-certified long-term care facilities and state veteran nursing homes in hot spots where the virus is has begun spiking again, according to a FierceHealthcare
- Vision Expo Announces Topic for July 22 Virtual EYE2EYE Series Coffee Talkhttps://modernod.com/news/vision-expo-announces-topic-for-july-22-virtual-eye2eye-series-coffee-talk/2478039/On July 22 at 12:15 pm EDT, The Vision Council and Vision Expo will host “Open Your Eyes! What Allyship of Diversity & Inclusion Looks Like” as part of the Virtual EYE2EYE Series, a weekly series of virtual panels and interactive conversations inspired by Vision Expo’s EYE2EYE edu
- Coburn Technologies Announces the New Velocity LTE Spin Coating Systemhttps://modernod.com/news/coburn-technologies-announces-the-new-velocity-lte-spin-coating-system/2477946/Coburn Technologies has released the newest edition of its Velocity coating platform, the Velocity LTE Spin Coating System, a space-saving, semi-automated spin coater that provides the control and ease of use needed by small to mid-sized labs, according to a company news release. Velocity
- AGTC Announces Productivity and Quality Enhancement To Its Proprietary Manufacturing Processhttps://modernod.com/news/agtc-announces-productivity-and-quality-enhancement-to-its-proprietary-manufacturing-process/2477916/Applied Genetic Technologies Corporation (AGTC) provided an update on the productivity and quality improvements made in its proprietary manufacturing platform that is currently being used to create clinical trial material for the company’s planned pivotal clinical trials in X-linked retinitis pig
- Coopervision Global Charity Releases its Annual Impact Report Highlighting Achievementshttps://modernod.com/news/coopervision-global-charity-releases-its-annual-impact-report-highlighting-achievements/2479515/As pediatric myopia increases globally in prevalence and severity, CooperVision remains committed to supporting programs such as “Our Children’s Vision” implemented by the Brien Holden Foundation that prioritize children’s eye health. Over the last 3 years, CooperVision has donated a
- Johnson & Johnson Vision Announces Global Initiatives to Support Eye Care Professionals and Patients During COVID-19 and Beyondhttps://modernod.com/news/johnson-johnson-vision-announces-global-initiatives-to-support-eye-care-professionals-and-patients-during-covid-19-and-beyond/2477770/Johnson & Johnson Vision is deploying solutions around the world to help address the challenges facing eye care professionals (ECPs) and their patients amid the COVID-19 pandemic. These support the broader efforts that Johnson & Johnson is taking to curb the crisis, including development
- VisionCare Announces CE Mark Approval of the Tsert-SI Delivery System for the CentraSight Treatment Programhttps://modernod.com/news/visioncare-announces-ce-mark-approval-of-the-tsert-si-delivery-system-for-the-centrasight-treatment-program/2477744/VisionCare has received CE Mark for the Tsert-SI delivery system for the CentraSight treatment program, which includes the Implantable Miniature Telescope (by Dr. Isaac Lipshitz). The Tsert-SI delivery system includes a pre-loaded telescope implant injector, which only requires a 6.5mm incision,
- Regenxbio Announces Additional Positive Long-Term and Interim Phase 1/2a Trial Update for RGX-314 for the Treatment of Wet AMDhttps://modernod.com/news/regenxbio-announces-additional-positive-long-term-and-interim-phase-1-2a-trial-update-for-rgx-314-for-the-treatment-of-wet-amd/2477630/Regenxbio provided additional long-term data from the ongoing phase 1/2a trial of RGX-314 for the treatment of wet age-related macular degeneration (AMD). In the phase 1/2a trial of RGX-314, 42 patients with severe wet AMD requiring frequent anti-vascular endothelial growth factor (anti-VE